A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 41,873 shares of ACRS stock, worth $121,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,873
Previous 41,873 -0.0%
Holding current value
$121,012
Previous $46,000 4.35%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.64 - $6.49 $16,982 - $172,212
26,535 Added 173.0%
41,873 $44,000
Q4 2022

Feb 08, 2023

SELL
$14.33 - $18.37 $2,866 - $3,674
-200 Reduced 1.29%
15,338 $242,000
Q3 2022

Oct 17, 2022

BUY
$13.07 - $18.22 $2,614 - $3,644
200 Added 1.3%
15,538 $244,000
Q3 2021

Nov 02, 2021

BUY
$13.38 - $18.8 $8,536 - $11,994
638 Added 4.34%
15,338 $276,000
Q1 2021

May 07, 2021

SELL
$5.86 - $27.73 $176,227 - $833,924
-30,073 Reduced 67.17%
14,700 $370,000
Q4 2020

Feb 04, 2021

BUY
$2.65 - $7.61 $193 - $555
73 Added 0.16%
44,773 $289,000
Q3 2019

Nov 06, 2019

BUY
$0.79 - $2.47 $35,313 - $110,409
44,700 New
44,700 $48,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.